Argon Strengthens Biopsy Portfolio with SuperCore Advantage™ Instrument
PLANO, Texas, May 31, 2023 /PRNewswire/ -- Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology, announced the launch of the SuperCore Advantage™ Semi-Automatic Biopsy Instrument as the newest addition to its soft tissue biopsy product portfolio in the United States.
- PLANO, Texas, May 31, 2023 /PRNewswire/ -- Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology, announced the launch of the SuperCore Advantage™ Semi-Automatic Biopsy Instrument as the newest addition to its soft tissue biopsy product portfolio in the United States.
- The SuperCore Advantage is a disposable, next generation soft tissue biopsy instrument that provides a superior volume of tissue samples*.
- Adding the SuperCore Advantage to this portfolio among other segment leaders like the BioPince Ultra® Full Core Biopsy Instrument, will fortify our reputation as a leading provider of soft tissue biopsy devices," said Tom Younker, Senior Vice President of Global Marketing, Argon Medical.
- Argon also offers the SuperCore™ Semi-Automatic, Tru-Core™ Automatic and Pro-Mag™ Ultra Biopsy Instruments.